• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

ECDC reflects on influenza season 2011/12 in its annual ?Influenza in Europe? surveillance report (October 15 2012)

Giuseppe

Emeritus
[Source: European Centre for Disease Prevention and Control (ECDC), full page: (LINK).]

ECDC reflects on influenza season 2011/12 in its annual ?Influenza in Europe? surveillance report

15 Oct 2012 / ECDC



A year?s worth of surveillance data are summarised in the new Influenza in Europe, Season 2011-2012 surveillance report. It concludes that the influenza season 2011/12 started late and there was no particular pattern in its geographical progression.

Its intensity was mild and unusually low in the majority of countries. Elderly and infants aged 0?4 years were the most severely affected groups of patients. With the return of A(H3N2) virus, a shift to older ages in severe influenza cases was observed.

The A(H1N1)pdm09 viruses continued to circulate, but they were largely exceeded by A(H3N2) and by B viruses, with the latter being especially important late in the season.

Genetic characterisations of A(H3N2) viruses have shown important antigenic diversity resulting in an imperfect match with the vaccine strain.

This was also reflected in the relatively low vaccine effectiveness observed and led to the WHO decision to recommend changing the seasonal influenza vaccine composition for the 2012?2013 season.

The influenza surveillance season in Europe lasts from beginning of October (week 40) of any given year to mid-May (week 20) of the following year, when ECDC provides weekly updates of influenza surveillance data.

Between seasons, more limited information is gathered on the virological characteristics of circulating viruses, quantitative clinical data and severe acute respiratory infections.

ECDC also maintains a year-round epidemic intelligence function to detect unusual events including those possibly related to influenza transmission.

The annual Influenza in Europe report is based on data and analyses covering all EU Member States, Iceland and Norway from week 40/2011 to week 20/2012 (not all participating countries contributed to each component of the surveillance system every week).



Resources on ECDC website:
-
-------
 
Back
Top